Discovery Life Sciences Ukraine

27/04/2023

We are excited to announce that Discovery Life Sciences has acquired ReachBio Research Labs! ReachBio’s expertise in cell-based assays, predictive… | 10 comments on LinkedIn

13/07/2022

Discovery Life Sciences and AllCells® have joined forces to create a new market leader in the procurement and customization of human cellular starting materials with integrated analytic services to advance cell and gene therapy programs.

AllCells, now a Discovery Life Sciences company, delivers a revolutionary set of scalable solutions to accelerate cell and gene therapy programs at every stage of development.

With more than 30 years of combined experience in CGT and a shared commitment to a Science at Your Service Approach, AllCells and Discovery are a single provider to help clients optimize their CGT programs from early research through commercialization.

“We are very excited to welcome the AllCells team to the Discovery family. Bringing these two great companies together creates a scalable, end-to-end solution that gives our clients unprecedented access to reliable human cellular starting materials with integrated multi-omic analytic services to support cell and gene therapies."

-- Glenn Bilawsky, CEO of Discovery Life Sciences

Read more about the recent acquisition and AllCells and Discovery’s new reliable, high quality human starting materials and analytical services for all stages of development at the link below.

https://www.dls.com/blog/discovery-life-sciences-acquires-allcells?utm_source=LinkedIn+&utm_medium=PR&utm_campaign=AllCells+Acquisition+PR

08/07/2022

We would like to welcome Discovery Life Sciences as our new Advisory Council Member. Discovery Life Sciences is a Biotechnology Research company which combines the world’s largest biospecimen inventory and procurement network with preeminent multi-omic service laboratories to accelerate precision medicine programs for cancer, infectious disease, and other complex conditions.

20/12/2021

Merry Christmas from DLS Ukraine!

18/05/2021

https://www.prnewswire.com/news-releases/discovery-life-sciences-acquires-targos-to-create-market-leading-global-tissue-biomarker-services-301290236.html

/PRNewswire/ -- Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, announced today that it has acquired Targos Molecular...

09/11/2020

https://www.prnewswire.co.uk/news-releases/discovery-life-sciences-becomes-the-global-market-leader-in-biospecimens-with-the-acquisition-of-europe-based-east-west-biopharma-884654674.html

/PRNewswire/ -- Discovery Life Sciences™ (Discovery), a global leader in biospecimen, genomic sequencing, cell, and immunohistochemistry (IHC) services,...

09/11/2020

East West Biopharma is now part of Discovery Life Sciences - Click below to see our new capabilities.

https://www.facebook.com/DLSciences

We are the biospecimen and biomarker specialists™, Biospecimen solutions and expert service laboratories to accelerate precision medicine programs.

07/07/2020

Wonders of the sea

Tiny animals with huge, lifesaving potential. 📕 Read more: https://bit.ly/2NOAmxw ... 72 comments on LinkedIn

02/07/2020

COVID-19 and Cancer

'...Fear of contracting the coronavirus in health care settings has dissuaded people from screening, diagnosis, and treatment for non–COVID-19 diseases. The consequences for cancer outcomes, for example, could be substantial.

Beyond clinical care, the COVID-19 pandemic has caused an unprecedented disruption throughout the cancer research community, shuttering many labs and slowing down cancer clinical trial operations. Many scientists and clinicians are pivoting their cancer research activities to study the impact of SARS-CoV-2 on cancer. The scientific community must ensure that this pause is only temporary, because trials are the only way to make progress in developing new therapies for cancer. Given the long timeline between basic cancer research and changes to cancer care, the effects of pausing research today may lead to slowdowns in cancer progress for many years to come...'

With the spread of coronavirus disease 2019 (COVID-19), countries and states have instituted lockdowns. These decisions have been difficult and are sometimes described as benefiting the public health at the expense of the economy. Fear of contracting the coronavirus in health care settings has dissu...

16/06/2020

Our work matters!

Pan-Cancer Analysis of Whole Genomes